FDA 10月27日警示勿用减肥产品Demograss Premier:实验室检出未标注成分酚酞,研究提示或增加致癌风险
美国食品药品监督管理局FDA于2026年10月27日发布公开通告,建议消费者不要购买或使用减肥产品Demograss Premier,该产品在包括innovacionnatural.com在内的多个网站上推广销售,也可能在部分零售店出售,FDA实验室分析确认该产品含有未在标签上标注的酚酞。
FDA表示,酚酞是一种化学物质,并非美国任何已批准药物的活性成分,研究提示它可能增加患癌风险。此次通告旨在提醒公众注意可能作为膳食补充剂或普通食品销售、含有隐藏成分的产品,这类产品通常以减肥、缓解疼痛、健身或增强性功能等名义推广,并常被宣传为纯天然。
FDA提醒,医疗专业人员和消费者如发现与使用该产品有关的不良事件或副作用,应向FDA的MedWatch安全信息与不良事件报告计划报告,可在线提交报告,或下载并填写表格后传真至1-800-FDA-0178。FDA同时表示,该机构无法对所有作为膳食补充剂销售、可能含有有害隐藏成分的产品逐一检测和识别,消费者在购买这类产品前应保持谨慎。
FDA Warns on October 27 Against Weight-Loss Product Demograss Premier: Lab Finds Hidden Ingredient Phenolphthalein
On October 27, 2026, the Food and Drug Administration (FDA) advised consumers not to purchase or use Demograss Premier, a product promoted and sold for weight loss on various websites, including innovacionnatural.com, and possibly in some retail stores. FDA laboratory analysis confirmed that Demograss Premier contains phenolphthalein not listed on the product label.
Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies suggest it may increase the risk of cancer, the FDA said.
The notification is intended to inform the public of products potentially marketed as dietary supplements or conventional foods with hidden ingredients. These products are typically promoted for sexual enhancement, weight loss, pain relief and body building and are often represented as being all natural, and consumers should exercise caution before purchasing them, according to the FDA.
Health care professionals and consumers should report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program, online or by fax at 1-800-FDA-0178. The FDA said it is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients.
来源：GSM·美国（原文链接）
图片来源：图：美国食品药品监督管理局FDA总部所在地——位于马里兰州Silver Spring的White Oak园区1号楼。照片：美国食品药品监督管理局（FDA），美国联邦政府作品、公共领域，经Wikimedia Commons。 / Building 1 on the FDA White Oak campus in Silver Spring, Maryland, the agency's administrative headquarters. Photo: U.S. Food and Drug Administration, public domain (U.S. federal government work), via Wikimedia Commons.
